All Type of News
Provision of Insurance Claim Re-Evaluations Gives More Choices for Healthcare Providers
The Health Insurance Review Agency (HIRA) announced that it has completed a necessary preparation for implementing a provision of re-evaluation request services for the National Health Insurance (NHI) reimbursement cl...
Government Aims to Expand Investigations on Current Wholesale Transaction Practices
In light of a recent discovery of counterfeit antihypertensive Novarsc medications that contain no therapeutic efficacy, the Korea Food and Drug Administration (KFDA) plans to undertake a joint investigative effort wi...
Court Rules Government to Abort Unilateral Disposition on Medical Insurance Drug Pricing
The recent ruling from the Seoul Administration Court to abort the unilateral disposition by the government to lower the medical insurance prices for certain ethical medications is creating repercussions in the domest...
MOHW Brings Forth Regulatory Reforms to Foster Neutraceutical Industry
As the government aims to outlay a successive provision of relief measures under its overall regulatory reform initiatives, the domestic neutraceutical industry and its constituents are encouraged over a positive pros...
Nation's Pharmacists Ask for Manufacturers' Participation on Inventory Return Initiative
The representatives from the nation's pharmacist interest groups released an official statement earlier this week, asking pharmaceutical manufacturers for their active and autonomous participations towards an initiati...
Continuous Demand and Valuation Erosions Towards Domestic Hospitals Available for Sale
Reflective of the protracted economic slowdowns, more hospitals were up for sale in the market during Year 2004 due to increasing financial difficulties, while both the demand and the asking purchase price levels were...
Clorox Korea Generates 55.8 Billion Won of Revenue, 4.16 Billion Won of Net Profit
Clorox Korea Ltd., a wholly owned domestic subsidiary of the Clorox International Company, announced that it recorded the total revenue of 55.8 billion won for the 14th annual fiscal period ending June 30th, 2004.
...
Heightened Competition Expected As Manufacturers Make New Product Introductions
A number of domestic pharmaceutical firms are attempting to boost their sales by introducing a number of brand new products to the market, estimated at twenty new items or more per each pharmaceutical company.
The ...
Separate Regulatory Supervision for Psychotropic Drugs Suggested
The Korea Hospital Association (KHA) recently made a suggestion to the Ministry of Health and Welfare (MOHW) to exclude psychotropic drugs from the existing list of narcotics that are subject to the government supervi...
Government, Healthcare Professionals Alarmed by Novarsc Counterfeits
According to a recent report released by the Korea Food and Drug Administration (KFDA), there are over 30 retail pharmacies that have dispensed the counterfeit Novarsc medications to the public, where an unauthorized ...
